NCT01708174 2017-08-11A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)NovartisPhase 2 Completed22 enrolled 12 charts
NCT01826214 2016-08-30Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute LeukemiaNovartisPhase 2 Completed70 enrolled 12 charts